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ABSTRACT: Highly sensitive electrical detection of biomarkers for the
early stage screening of cancer is desired for future, ultrafast diagnostic
platforms. In the case of prostate cancer (PCa), the prostate-speciﬁc
antigen (PSA) is of prime interest and its detection in combination with
other PCa-relevant biomarkers in a multiplex approach is advised. Toward
this goal, we demonstrate the label-free, potentiometric detection of PSA
with silicon nanowire ion-sensitive ﬁeld-eﬀect transistor (Si NW-ISFET)
arrays. To realize the ﬁeld-eﬀect detection, we utilized the DNA aptamer-
receptors speciﬁc for PSA, which were covalently and site-speciﬁcally
immobilized on Si NW-ISFETs. The platform was used for quantitative
detection of PSA and the change in threshold voltage of the Si NW-ISEFTs
was correlated with the concentration of PSA. Concentration-dependent
measurements were done in a wide range of 1 pg/mL to 1 μg/mL, which
covers the clinical range of interest. To conﬁrm the PSA−DNA aptamer
binding on the Si NW surfaces, a sandwich-immunoassay based on chemiluminescence was implemented. The electrical
approach using the Si NW-ISFET platform shows a lower limit of detection and a wide dynamic range of the assay. In future,
our platform should be utilized to detect multiple biomarkers in one assay to obtain more reliable information about cancer-
related diseases.
■ INTRODUCTION
Nanoscale ﬁeld-eﬀect transistors (FETs) have emerged as
versatile and multiphasic technological tools for the realization
of high-performance sensor applications.1 Chemical sensing or
biosensing in solutions require the operation of the FETs in an
electrochemical-gate conﬁguration. This is the classical ion-
sensitive ﬁeld-eﬀect transistor (ISFET) concept, where the
FET response is determined by changes in the surface
potential at the solid−liquid interface and by the composition
of the electrical double layer (EDL), which are both inﬂuenced
by the binding of charged molecules.2,3 The usage of one-
dimensional semiconductors such as silicon nanowires (Si
NWs) for ISFET platforms is advantageous because of their
high sensitivities toward surface-potential changes. Therefore,
Si NW-ISFETs are utilized for high-performance, “label-free”
electrical biosensors.4−6 In recent years, Si NW-ISFETs have
been described as an ideal candidate for diﬀerent bioassays
with an ever-increasing focus on novel concepts dealing with
label-free, continuous screening of various biomolecules from
complex biological media toward point-of-care (PoC)
applications.7−10
However, the use of nanoscale ISFETs for real applications
remains challenging due to intrinsic limitations. Their electrical
characteristics are largely inﬂuenced by the composition of the
EDL. Thereby, they suﬀer from diminished performance for
biodetection in physiological solutions due to EDL contraction
or Debye screening of the biomolecule charges (typically <1
nm for physiological saline or biological ﬂuids).8,11,12 Strategies
to overcome this Debye screening for PoC biosensor
applications in blood serum have included physical manipu-
lation of the solid−liquid interface by polymer spacer layers,
rendering of nanoscale features, or alternating the working
requirements.13−17 Alternative approaches to counteract
Debye screening rely on the use of nanoscale capacitors
operated at high frequencies and the impedimetric readout
strategies with ISFETs.18−20 Here, microﬂuidics-integrated
sensors have demonstrated great potential toward label-free
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bioassays for screening of a variety of biomarkers directly in
physiological saline or human serum.10,21−24
Si NW-ISFET concepts are especially interesting for
industrial upscale due to the possible mass-production using
state-of-the-art, top-down nanofabrication methods (e.g.,
nanoimprint lithography (NIL) or extreme ultraviolet
lithography).25,26 In our previous work, we described a NIL
approach for wafer-scale, high-density fabrication of Si NW-
ISFET arrays with identical sensor characteristics.27 In this
work, we deploy these Si NW-ISFETs as label-free electrical
biosensors to realize simple and direct potentiometric
screening of prostate-speciﬁc antigen (PSA), a 33 kDa single-
chain glycoprotein. A healthy man has a PSA level <4 ng/mL
in serum, whereas increased PSA concentrations may indicate a
risk of prostate cancer. Also, the increased rate of PSA level
over time is a solid diagnostic evidence and therefore multiple
and swift tests over time would enable better healthcare. For
risk stratiﬁcation, an increased serum PSA level is usually
complemented with biopsies followed by tissue examination.28
These procedures are sometimes unnecessary and can even
cause over diagnosis of risks in some patients.29−34 The direct
screening and close monitoring of PSA together with newer
biomarkers such as glycoproteins and micro-RNAs may reduce
the painful tissue examination procedures in the future.
Unlike other sensor platforms described in literature for the
label-free detection of PSA with PSA-speciﬁc antibodies as
receptors, our Si NW-ISFETs were functionalized with DNA
aptamers speciﬁc to PSA.35−44 Specially designed aptamers
mimicking the binding site conformations of target analytes
have a strong advantage over antibody receptors, particularly
for ﬁeld-eﬀect sensing due to their much smaller size.13,42,45−48
In this work, we show a high speciﬁcity and a robust binding of
PSA toward the aptamer functionalized Si NW surfaces. The
small sizes typically within a few nanometers and the negatively
charged DNA sequences of the aptamers render the solid−
liquid interface with a deﬁned surface charge density.
Therefore, the use of aptamers as biofunctionalization layer
is advantageous for ﬁeld-eﬀect sensing of large biomolecules.
This is demonstrated in this work for screening of PSA with a
dynamic concentration range spanning over 5 orders of
Figure 1. Realization of the Si NW-ISFET sensor platform: photograph of a top-down fabricated sensor chip with Si NW-ISFETs mounted onto a
PCB and wire-bonded to facilitate external electrical contacts (a), an electrical circuit diagram for the operation of the Si NW sensors (b), surface
characterization of a set of four Si NWs using AFM and representation as a three-dimensional image showing identical structural characteristics (c),
schematic illustration of the surface functionalization and build-up of the biofunctional layer on the Si NW surface for label-free electrical detection
of PSA (d), photograph of a sensor chip with a ﬂuidic layer assembled on top to facilitate easy handling of analytes (e), and microscopic top view of
the microﬂuidic channel in poly(dimethylsiloxane) (PDMS) aligned over 8 sets of Si NWs on top of the 32-channel Si NW-ISFET chip, also
showing common source and individual drain contact lines (f).
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magnitude while fully covering the clinically relevant
concentration range.
Furthermore, we compare the response of the aptamer-
modiﬁed Si NW-ISFETs with microscale Si ISFETs.49 The
nanoscale devices show a much better response for label-free
electrical biosensing. As a control assay, we detected the
binding of PSA by chemiluminescence on the chip surfaces,
which also conﬁrmed the highly-speciﬁc binding to the
aptamer receptors. The Si NW-ISFET aptasensor arrays
achieved a high performance for the label-free detection of
PSA biomarkers in a concentration range from 3 pM to 30 nM
(10 pg/mL to 1 μg/mL). Our optimized Si NW-ISFET
aptasensor platform therefore oﬀers a straightforward ﬁeld-
eﬀect detection of globular biomolecules. Enabled with a
miniaturized handheld readout, multiplexing approaches
combining similar sensor arrays for other candidate biomarkers
on this sensor platform can be promising in the near future for
high-throughput clinical assays towards PoC screening of
cancer biomarkers in general.21,50−53
■ RESULTS AND DISCUSSION
Top-down nanofabrication of enhancement-mode, p-type Si
NW-ISFETs with an optimized lithography protocol was
earlier developed in our group and the realization of high-
aspect-ratio Si NWs on 4 in. silicon-on-insulator (SOI) wafers
was demonstrated.27 It was conﬁrmed that the resulting arrays
of Si NWs exhibited high-quality SiO2 gate dielectrics after
anisotropic wet etching and dry oxidation, resulting in superior
Figure 2. Statistical evaluation of the sensing behavior of the Si NW-ISFETs for the detection of PSA: shift in Vth of a typical Si NW-ISFET after
diﬀerent surface immobilization steps including GPTMS, aptamer, EA functionalization, and 30 nM PSA binding (a), transfer characteristics of a Si
NW-ISFET without aptamer functionalization as a negative control (b), sensor responses of 27 out of 32 Si NWs from a single sensor chip with and
without aptamer functionalization. The recordings are shown in one graph as the change in Vth values before and after binding of 30 nM PSA (c).
The large number of channels on one chip enables us to statistically evaluate multiple experiments. The histogram shows the average changes in Vth
during surface immobilization steps with and without aptamers. A statistical analysis of these changes was done with a paired t-test (d). The dot
chart shows the change in average Vth of diﬀerent Si NW sets (four Si NWs each) on one-sensor chip before and after analyte binding (e). Average
Vth change of these Si NW sets at each immobilization step is represented as average value ± standard deviation. When evaluating all sensors, the
paired t-test shows signiﬁcance for all steps (*** = P < 0.001, ** = P < 0.01 and ns for nonsigniﬁcant) (f).
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sensor characteristics with low electrical hysteresis and
identical sensors over wafer scale. The usage of p-type devices
has a chemical reason in particular when only SiO2 is used as
gate dielectrics. In case of n-type, the cations from the
electrolyte solution intercalate into the porous oxide driven by
the gate bias voltage causing break down of the dielectrics and
malfunctioning of the sensors. Better performance is reported
for other gate dielectrics like Al2O3 or HfO2, which we aim to
integrate in a later stage of our project as well. Fabrication
details of the devices are summarized in the Materials and
Methods section. A typical sensor chip with Si NWs arrays is
shown in Figure 1. Figure 1a shows a photograph of a sensor
chip that was mounted on a specially designed printed circuit
board (PCB) to enable external electrical contacts for the Si
NW-ISFET source and drains. Figure 1b illustrates an electrical
circuit diagram for the operation of the Si NW-ISFETs. As it
can be seen from Figure 1b, the source is grounded, whereas a
negative bias is applied to the drain, resulting in a drain−
source voltage Vds. An Ag−AgCl reference electrode is
immersed into the electrolyte solution and used to apply the
front-gate voltage Vgs, whereas the drain−source current Ids is
measured via an ampliﬁer. In this conﬁguration, the back-gate
contact was grounded and therefore ﬁxed to the same potential
as the source contact. Figure 1c shows a three-dimensional
representation of an atomic force microscopy (AFM) scan of a
typical set of Si NWs connected to a common source and four
individual drains. Each Si NW with a trapezoidal cross section
measured 14 μm in length, 67 nm in height, and 250 nm in
width at the base. The Si NWs had a thermally grown gate
oxide layer (6−8 nm) for ISFET operation as well as for
providing hydroxyl groups for subsequent chemical surface
modiﬁcations.
The schematic illustration in Figure 1d shows the covalently
functionalized aptamer sequences (32 nucleotides) as a PSA-
speciﬁc biofunctional layer on a Si NW. More information on
the aptamer sequence and the surface functionalization
protocols is provided in the Materials and Methods section
as well as in the Supporting Information (Figure S1). Figure
1e,f shows the integration of a microﬂuidic channel on top of
the sensor chip realized in a poly(dimethylsiloxane) (PDMS)
layer. The microﬂuidic channel was aligned over the Si NW
sets, which can be seen in the microscopic image taken
through the PDMS layer (Figure 1f).
Aptamer-functionalized Si NW-ISFETs were then deployed
for the electrical detection of PSA, and initial ﬁndings on the
sensor performance are summarized in Figure 2. Measure-
ments were carried out in phosphate buﬀer (PB) at pH 7.4
while applying a drain−source bias of −100 mV and sweeping
a gate voltage against an Ag/AgCl reference electrode from −1
V to −100 mV. Transfer characteristics of a typical Si NW-
ISFET recorded with these parameters are shown in Figure 2a.
The black curve in Figure 2a represents the transfer
characteristics of a Si NW-ISFET modiﬁed with 3-glycidox-
ypropyltrimethoxysiloxane (GPTMS) using a high-quality gas-
phase silanization protocol.54 In the ﬁeld of biosensor research
also, other abbreviations for this type of silane are used such as
GPTES or GOPS. Main advantage of using this silane instead
of the more common (3-aminopropyl)triethoxysilane is that
cross-linking with additional molecules such as succinic
anhydride can be omitted.55 The direct link of amino-
functionalized capture molecules to the GPTMS layer is
advantageous for the ﬁeld-eﬀect detection resulting in a smaller
distance of the analyte molecules to the sensor surface after
binding. A threshold voltage (Vth) shift toward positive gate
voltages was observed after surface functionalization with PSA-
speciﬁc aptamers, shown as the red curve in Figure 2a. Amino-
modiﬁed aptamers were used as receptors. They can covalently
bind to the glycidol functional groups of GPTMS while
introducing additional negative charges to the solid−liquid
interface. Therefore, a decrease in Vth of the Si NWs upon
binding of aptamers is observed.53,56 The successful function-
alization of aptamers onto the Si NW surfaces was also
conﬁrmed by AFM measurements, which are discussed in the
Supporting Information in Figure S2. The average size of the
PSA-speciﬁc aptamers with 32 nucleotides is about 10 nm in
length and about 1.2−1.8 nm in thickness. In a 10 mM ionic
strength PB, the Debye length is about 2 nm. With comparable
sizes of aptamers and EDL, we expect an eﬃcient change in the
EDL composition upon binding of aptamers, which is evident
from the strong threshold shifts in the transfer characteristics.27
To avoid nonspeciﬁc binding of analyte PSA, a molecular
blocking layer of ethanolamine (EA) was used. This step was
applied to the whole chip surface and should block the
nonfunctionalized surface groups of the aptamer-modiﬁed
regions as well as the nonmodiﬁed surfaces next to the
microspots when the microspotting procedure was used in
some experiments (for details, please refer to the Supporting
Information S3). The binding of EA to the Si NW-ISFET
surfaces induced a decrease in Vth of several 100 mV (Figure
2a). After this blocking step, the aptamer sensor platform was
ready for the detection of PSA.
A PB solution containing 30 nM enzymatically active PSA
from human seminal ﬂuid was applied to the sensor platform
and allowed to bind to the sensor surfaces. The resulting
transfer characteristic of a typical Si NW-ISFET is shown in
Figure 2a (blue curve). It is known from conformational
studies that DNA aptamers form adaptable secondary and
tertiary structures to bind with their target analytes.48 These
conformational binding mechanisms are responsible for a
sometimes even higher speciﬁcity and aﬃnity of aptamer
receptors compared to their antibody counterparts.42 Some
portions of the negatively charged phosphate backbones of the
aptamers are shielded during this conformational adaptation
upon binding with PSA and therefore a reduction in total
density of negative surface charges on the solid−liquid
interface is possible.43 It was also earlier reported that the
isoelectric point of PSA can vary in a wide range from pH 6.4
to 8 because of the variable degree of its glycosylation.38,57,58
We assume that the Vth increase upon binding of PSA to the
DNA aptamers on the Si NW surfaces is caused by a positive
charge addition onto the surface. Therefore, for our experi-
ments, the PI of this particular PSA in its glycosylation state
should be higher than 7.4. The aptamer−PSA binding causes
an increase in Vth of the Si NW-ISFETs.
To conﬁrm the speciﬁcity of the sensor signal, we applied
the same 30 nM PSA in PB solution to Si NW-ISFETs without
aptamer functionalization as controls. The response of a
control sensor is shown in Figure 2b. As can be seen from the
blue and green curves of Figure 2a,b, respectively, the sensor
response was highly speciﬁc. However, individual responses
were underlying statistical variations. With the 32-channel Si
NW-ISFET sensor chips (arranged in 8 sets of 4 Si NWs each),
we were able to statistically evaluate the sensor platform. In
Figure 2c, it is shown that the platform could also be utilized
with on-chip control channels. A typical experiment is shown,
where 27 out of 32 channels were electrically functioning.
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Sensor positions from 1 to 20 were functionalized with PSA-
speciﬁc aptamers, whereas 21−32 were not functionalized with
the aptamer. In this experiment, the site-selective functional-
ization was realized with a DNA microspotter. More
information about the microspotting procedure for function-
alization of aptamers and the inﬂuence of the microspotting to
the Si NW-ISFET performance is provided in the Supporting
Information (Figure S3). This experiment also details how our
platform could be utilized for the parallel detection of multiple
analytes. As can be seen from the graph in Figure 2c, changes
in Vth values were consistent over all the sensor positions with
some variations in absolute values. The changes in the Vth
values after PSA interaction were much higher for the sensor
positions functionalized with the aptamer. However, because
the microspotting protocol was a tedious procedure, for the
statistical evaluation of all experiments described in the
following, only whole-chip surfaces of Si NW-ISFETs were
functionalized for better reproducibility of sensor character-
istics and higher throughput in the experiments. Figure 2d
compares the average shifts in the Vth value for the aptamer-
functionalized and nonfunctionalized sensors. The average Vth
values of the control channels did not change (PB), whereas
the aptamer functionalization of the other channels caused a
shift. A paired t-test analysis of the sensor response conﬁrmed
nonsigniﬁcant changes (ns) for controls in comparison to
aptamer-functionalized Si NWs (*** for P < 0.001). The
blocking step with EA also caused signiﬁcant changes in the
sensor channels and controls, whereas the binding of 30 nM
PSA induced statistically signiﬁcant changes in the sensing
channels (*** for P < 0.001) in comparison to ns for control
channels. Therefore, in later experiments, the relative PSA
responses are always plotted with respect to the EA transfer
characteristics.
When evaluating the individual sets of one Si NW-ISFET
sensor chip (four Si NWs per each set), the variation in ﬁve
diﬀerent sets is shown in Figure 2e. This experiment was done
with aptamer-functionalized sensors and 30 nm PSA in PB was
applied as an analyte solution. In four out of ﬁve cases, the
sensors show a signiﬁcant response. The complete analysis of
the response of these ﬁve Si NW sets is shown in Figure 2f.
Figure 3. Testing the performance of the biofunctional layers on the Si NW-ISFET surfaces using a chemiluminescence assay: schematic
illustrations showing the build-up of the biofunctional layers for the chemiluminescence assay (a, b). Microscopic images showing the
chemiluminescence intensities for the detection of analyte PSA using the speciﬁc aptamer sequence. Also, in the case of PB without PSA, the anti-
PSA HRP antibodies bind to the speciﬁc aptamers. Nevertheless, a chemiluminescence increase with increasing PSA concentration can be seen (c).
In the case of the nonspeciﬁc PSA aptamer receptors also, the anti-PSA HRP antibodies did not bind nonspeciﬁcally, showing no
chemiluminescence signal (d). The histogram displays the average chemiluminescence intensity (arbitrary units) of all experiments with PSA-
speciﬁc and nonspeciﬁc aptamers. A paired t-test shows signiﬁcance only in the higher concentration level (ns for not signiﬁcant, *** for P < 0.001,
** for P < 0.01 and * for P < 0.1) (e).
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Statistically signiﬁcant (*** for P < 0.001 and ** for P < 0.01)
variations in Vth shifts were observed at each surface
modiﬁcation step, as well as for the sensor response towards
30 nM PSA. Therefore, we can conclude that the Si NW-
ISFET platform oﬀers stable and reproducible responses, and
that it can be utilized for speciﬁc detection of PSA.
For real diagnostic applications, a PSA test should be most
precise at a concentration level of around 4 ng/mL (0.12 nM),
whereas depending on the age group and ethnic background,
levels lower than 0.1 ng/mL (3 pM) can be measured in
healthy men, but levels of 4 ng/mL and higher suggest further
diagnostics in terms of biopsy. Commercially available
diagnostic tests cover concentration ranges of 0−50 ng/mL
(0−1.5 nM), with limits of detection (LOD) as low as around
0.05 ng/mL (1.5 pM).59 We deﬁned this concentration range
as the “range of interest” for our Si NW-ISFET assays. In this
range, an optimum sensor for PSA detection should show
highest sensitivity (i.e., sensor signal/concentration), which is
the slope in the dose−response curve. At best, the relation
between the sensor signal and the given concentration is linear,
which is very rare for aﬃnity-based sensor approaches. In
general, it is important that the calibration curve shows a very
small statistical error with good reproducibility between the
data points to enable an optimum resolution of the sensor in
the range of interest. From related publications in our
European project PROSENSE, we know that the aptamers
used in this publication show a very good binding of analyte
PSA with high association constants.60,61
First, to optimize our Si NW-ISFET sensor platform toward
the electrical detection of PSA with lower concentrations in the
sample and to conﬁrm the speciﬁc binding of PSA to the
receptors, we utilized two optical assays with chemilumines-
cence and ﬂuorescence detection, respectively. The chem-
iluminescence sandwich immunoassay for the detection of PSA
is schematically depicted in Figure 3. Figure 3a,b shows a
schematic illustration of this assay, where the Si NWs are either
functionalized with PSA-speciﬁc aptamers (Figure 3a) or
nonspeciﬁc aptamers (Figure 3b) of the same sequence length
(32 bases) as controls. These experiments were done inside the
PDMS microﬂuidic channels of 100 μm width, which were
mounted onto the Si NW-ISFET chip surfaces. By this
procedure, the channel can be compared with the PDMS-
protected surface as the background. The analyte PSA solution
was ﬂown through the microﬂuidic channels and allowed to
bind to the aptamer surfaces. After this, PB solution with anti-
PSA horseradish peroxidase (HRP) antibodies was ﬂown
through the microﬂuidic channels and allowed to bind to the
immobilized PSA. The substrate luminol (5-amino-2,3-
dihydrophthalazine-1,4-dione) was excited by oxidation to
form an intermediate state using H2O2. The luminol in the
excited intermediate state was then allowed to react with the
anti-PSA HRP antibodies bound on the Si NW surfaces. The
Figure 4. Label-free, fully electronic detection of PSA with Si NW-ISFETs: the histogram demonstrates how each chip was evaluated for the
bioassay. Small standard deviation should be noted for multiple Si NWs from one chip. Here, a control experiment is evaluated, which shows the
stability of the sensor platform. The average change in ΔVth at each step of surface functionalization is displayed. The paired t-test results in ** = P
< 0.01, * = P < 0.1, ns = nonsigniﬁcant (n = 2 independent experiments) (a); typical ﬁeld-eﬀect response of one Si NW-ISFET functionalized with
the PSA-speciﬁc aptamer and tested with PSA concentrations varying from 0.3 pM to 30 nM (b); typical ﬁeld-eﬀect response of a control Si NW-
ISFET without aptamer functionalization at the same PSA concentrations conﬁrming the PSA-speciﬁc sensor response (c). The scatter chart
summarizes the absolute Vth shifts as a function of increasing PSA concentrations for repeated experiments, where the results were baseline
corrected to the smallest concentration of 0.3 pM (n = 2) (d). The errors bars diﬀer because we evaluated several channels from two independent
chips for the PSA concentration tests and several channels from one control chip. Data points represent average values ± standard deviations.
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reaction of luminol with the HRP enzyme returned it to the
ground state with an emission of a photon. This photon
emission then indirectly conﬁrmed the presence of PSA on the
Si NW surfaces.
In this chemiluminescence assay, the intensity of the optical
signal is directly related to the amount of anti-PSA HRP
antibodies bound to PSA. It is therefore indirectly related to
the concentration of PSA in the analyte solution, when a
nonspeciﬁc binding of the antibodies to the surface can be
excluded.62 Details of the surface modiﬁcation and other
procedures used in the chemiluminescence assay are provided
in the Materials and Methods section. Figure 3c shows the
microscopic images of the chemiluminescence generated inside
a microﬂuidic channel on the surface of a Si NW-ISFET chip
upon the interaction of luminol with anti-PSA HRP antibodies.
In general, this optical method is not sensitive enough for very
low concentrations of PSA. The PSA concentrations of 1.5 nM
(50 ng/mL) and 3 nM (100 ng/mL) were tested, and
signiﬁcant increase in chemiluminescence intensity can only be
seen with a higher concentration of PSA (Figure 3c; bottom
images).
To ascertain the speciﬁcity of the optical signals, two control
experiments were performed. First, the chemiluminescence
intensity for the interaction between anti-PSA HRP antibodies
and PSA-speciﬁc aptamers on the Si NW-ISFET surfaces was
measured, such as shown in Figure 3c (top image), where the
PB did not contain PSA before ﬂowing the anti-PSA HRP
antibody solution through the channel. It can be seen that the
anti-PSA HRP antibodies also binded unspeciﬁcally to the
PSA-speciﬁc aptamers, leading to a background signal. In
contrast, the nonspeciﬁc aptamer sequence did not bind the
anti-PSA HRP antibodies (Figure 3d). This suggests a small
cross-reactivity between anti-PSA HRP antibodies and PSA-
speciﬁc aptamers, which would need to be avoided by a
blocking step. For further optimization of the assay, this
blocking step is a crucial element that needs more attention.
However, other researchers in the ﬁeld optimized such DNA
aptamer assays on glass slides,63,64 and we could apply and
adapt the same principles to our SiO2 sensors surfaces. The
statistical evaluation of all chemiluminescence experiments that
showed variation in chemiluminescence intensity as a function
of PSA concentration is presented in the histogram plot of
Figure 3e. Signiﬁcance was conﬁrmed for the interactions of
the PSA-speciﬁc aptamers with PSA in comparison to
nonspeciﬁc interactions at lower concentrations (ns for not
signiﬁcant, *** for P < 0.001, ** for P < 0.01, and * for P <
0.1).
These results conﬁrm that the surface chemistry on the Si
NW-ISFET surfaces is robust, and that the aptamer receptor
layer speciﬁcally captures PSA from the analyte solution. The
second optical method based on direct ﬂuorescence detection
with anti-PSA ﬂuorescein isothiocynate antibodies was less
sensitive. Fluorescence assay results with 30 nM PSA in PB are
provided in the Supporting Information S4.
After the conﬁrmation of a PSA-speciﬁc binding in the
chemiluminescence assays, the Si NW-ISFET sensor platform
was evaluated for the electronic detection of the ultralow
concentrations of PSA. Concentrations of 0.3 pM, 3 pM, 30
pM, 300 pM, 3 nM, and 30 nM (1 pg/mL to 1 μg/mL) were
tested. This concentration range widely covers the clinically
relevant concentrations of PSA as prostate cancer biomarker in
men. The sensor responses of the Si NW-ISFETs are
summarized in Figure 4. First, we tested the stability of the
platform by control measurements with PB solution without
PSA while comparing the threshold voltage changes (ΔVth) at
all surface modiﬁcation steps (Figure 4a). The sensors
demonstrated identical characteristics for all steps with low
standard deviations and statistically meaningful (paired t-test)
shifts in Vth (ns for nonsigniﬁcant, ** for P < 0.01 and * for P
< 0.1). As shown in Figure 4a, the responses were
nonsigniﬁcant for the interaction of PB buﬀer without PSA
analyte molecules. Therefore, we can exclude the eventual
washout eﬀects of the biorecognition layer. It should also be
noted that the standard deviations increased from step-to-step
during surface modiﬁcation. From this stepwise increase, we
can conclude that with each surface functionalization step, the
Si NW-ISFET chip surfaces get less uniform, resulting in
higher variations in the signals from diﬀerent locations of the
chip surface. For further optimization of the PSA assay, this
increasing nonuniformity should be optimized as well.
The performance of a Si NW-ISFET with diﬀerent
concentrations of PSA is shown in Figure 4b. It can be seen
that the transfer characteristics shifted toward decreasing Vth
values with increasing PSA concentration. A control Si NW-
ISFET modiﬁed without the PSA-speciﬁc aptamers is shown in
Figure 4c. As can be seen, the transfer characteristics did not
show any signiﬁcant shift in Vth. Figure 4d summarizes the
dose−response curves of all the experiments with the Si NW-
ISFET platform, where relative threshold voltage changes
(ΔVthcompared to the values after EA blocking) are plotted
on the y-axis against the PSA concentrations (x-axis) from 0.3
pM to 30 nM. To compare diﬀerent Si NW-ISFET chips, the
shifts were baseline corrected (ΔVth = 0 V) to the lowest PSA
concentration tested. A clear and signiﬁcant increase in sensor
signal is already visible at a PSA concentration as low as 3 pM.
Control signals remained stable until a slight increase in the
highest concentration of 30 nM, which we attributed to
unspeciﬁc binding of PSA to the control surfaces. In Figure 4d,
the range of interest is indicated, and it can be seen that our
highly sensitive Si NW-ISFET platform already detected
signiﬁcant responses in a low PSA concentration regime. It is
to be noted that the values for the detection channels display
several sensors from two 32-channel Si NW-ISFET chips,
whereas the control displays channels from one control chip
(average ΔVth ± standard deviation). Therefore, the error bars
for the PSA detection are a bit larger. Unfortunately, our
sensor platform yet does not show the necessary resolution in
the critical concentration range of about 4 ng/mL (120 pM),
which would be needed for critical diagnostic decisions toward
eventual biopsies. However, the sensor response is already
strong and statistically signiﬁcant at much lower concentration
levels, which was also reported in related works using the same
aptamer sequences.60,61 This would eventually also allow
dilution and conditioning of clinical samples with conditioning
buﬀer before PSA tests, which is advantageous to stabilize side
parameters such as ionic strength and pH value of the test
solution. In addition, also for PSA concentrations beyond this
concentration level, a further signal increase can be seen
(Figure 4d; concentrations larger than 3 nM), which we
attribute to unspeciﬁc binding to the PSA-speciﬁc aptamer
surfaces (consistent with also the signal increase in the
controls).
Similarly, ultrasensitive detection of PSA with other silicon
nanowire platforms was earlier reported in literature. In Table
1, we compare the performance of our top-down fabricated
aptamer Si NW-ISFET platform with contemporary studies for
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label-free detection of PSA with silicon nanowires. In our assay,
we cover a wide concentration range with an LOD clearly
below 50 pg/mL, which would be the necessary value for
diagnostic applications.
In general, the ultrasensitive detection of biomolecules with
Si NW platforms originates from the high surface-to-volume
ratio of the Si NWs and precise surface charge properties
attenuated with the use of small receptor molecules such as
aptamers.43,44,66 We also adapted our PSA bioassay protocol to
microscale ISFETs of silicon. The sensitivity toward the
detection of PSA was much lower in this case (see the
Supporting Information, Figure S5).
In the future, the adaptation of our Si NW-ISFET platform
to a speciﬁc diagnostic PSA test would be possible because the
most sensitive regime was clearly below the concentration
regime of the highest interest (4 ng/mL). The necessary
sample dilution would even be advantageous for diagnostic
assays because this procedure could be utilized to condition
the analyte solution and control the main side parameters such
as the ionic strength and pH. By this procedure, the wide
response window of our platform could be adapted to the
concentration range of diagnostic interest.
■ CONCLUSIONS
A platform based on top-down fabricated Si NW-ISFET arrays
was successfully deployed for the detection of PSA in the
clinically relevant concentration range from 0.3 pM to 30 nM.
We utilized highly speciﬁc aptamers to capture PSA from
diluted phosphate buﬀer solutions. Such aptamer receptor
molecules have the advantage of being very small compared to
antibodies, which is beneﬁcial for ﬁeld-eﬀect detection on
surfaces, where the distance of the analyte molecules to the
surface is crucial. Other clear advantages of aptamer receptors
are the robustness and storage time compared to many other
approaches as described in literature.63,64 The protocol for the
biofunctionalization of the sensors was carefully build up step-
by-step and binding of the molecules to the surfaces was
conﬁrmed by AFM. In addition, the speciﬁc binding of PSA to
the PSA-speciﬁc aptamer receptors was conﬁrmed by
chemiluminescence and ﬂuorescence detection, which we
performed inside the microﬂuidic channels mounted on top
of the chip surfaces. Compared to two optical methods, the
ﬁeld-eﬀect detection with Si NW-ISFETs method showed
higher sensitivity with statistically signiﬁcant shifts in threshold
voltages. This fully electronic detection with our platform
achieved a lower LOD as well. The fabrication protocol of the
sensor platform was established in a top-down wafer-scale
process resulting in Si NW-ISFETs with nearly identical sensor
characteristics. This enabled a reliable and reproducible sensor
performance, where we could utilize chip-to-chip controls.
Using a microspotter, we also demonstrated the possibility of
an on-chip control, which will be mandatory for the realization
of future diagnostic assays. In addition, the highly reproducible
sensor sites of our Si NW-ISFET platform would enable
simultaneous detection of multiple analytes on one chip like in
typical glass microarray bioassays with ﬂuorescence readout.
We demonstrated the experimental capability with a precise,
site-selective microspotting procedure, but we did not utilize
this technique to prime the diﬀerent sensors of the Si NW-
ISFET arrays with diﬀerent capture molecules. For future
optimization, the highly minaturized Si NW-ISFETs would
eventually allow an integration into readout tools for mobile
use because the power consumption of ﬁeld-eﬀect detection is
in general and with highly miniaturized Si NW-ISFETs in
particular very low. In our assay, however, we yet did not reach
the necessary resolution in the most critical concentration
range of ∼4 ng/mL, which is typically associated with the
onset of prostate cancer. Because the LOD was much lower
than this concentration level, a sample dilution would be
possible to condition the patients’ serum stabilizing the pH
value while reducing the ionic strength to boost the sensitivity
of the detection. So far, we only tested in saline solution with
slightly elevated salt concentration. For future developments
toward clinical applications, selectivity in complex media needs
to be tested. One major advantage of our platform is that in
principle, it also allows for parallel analysis of multiple
biomarkers. For this then, the surface functionalization and
in particular the blocking step before the detection need to be
optimized.63,64 Our Si NW-ISFET platform therefore provides
a viable substitute for a high-throughput and multiplexed
analysis toward other bioassays as well.67 Equipped with high-
density integration of sensor sites and parallel readout options,
such sensor platforms are in future expected to generate
actionable diagnostic information for PoC medical diagnostics.
■ MATERIALS AND METHODS
Materials. Amine-terminated, PSA-speciﬁc DNA aptamer
(5′-NH2-(CH2)6-TTTT TAAT TAAA GCTC GCCA TCAA
ATAG CTTT-3′), nonspeciﬁc aptamer (5′-H3N-(CH2)6-
AAAAATTAATTTCGAGCGGTAGTTTATCGAAA-3′),
ethanolamine (EA), and GPTMS were purchased from Sigma-
Aldrich, Germany. PSA was obtained from Merck Chemicals
Ltd. (Beeston, U.K.). For the electronic assays, PB with pH 7.4
and 10 mM concentration was prepared from monohydrate
phosphate and dinatrium hydrogen phosphate salts. Anti-PSA
antibodies [5A6]-HRP (catalog no. Ab2446) and anti-PSA-
ﬂuorescein isothiocyanate antibodies (catalog no. Ab178776)
were purchased from Abcam, U.K. Luminol (SuperSignal West
Femto Substrate Trial Kit 34094) was purchased from Thermo
Scientiﬁc, Portugal. All the other reagents were of analytical
grade. Metallic plug adapters for the microﬂuidic channel and
capillary tubing (BTPE-90) were purchased from Instech
Solomon (PA). One milliliter syringes were purchased from
CODAN, Germany. The liquid ﬂow in the microﬂuidic
channel for the optical immunoassays was controlled using a
NE-300 syringe pump from New Era (NY).
Fabrication of the Sensor Chips. The fabrication process
of Si NW-ISFETs was reported earlier.27 In short, the sensor
chips were fabricated on SOI wafers using a combination of
nanoimprint lithography and photolithography processes.27
Depending on the dimensions of the SiO2 hard mask, which
we used in our processes, we got diﬀerent values for absolute
Table 1. Performances of Other Silicon Nanowire ISFET
Sensor Platforms for Label-Free Detection of PSA
Described in the Scientiﬁc Literature
sensor platform performance references
trimmed Si NW-ISFETs 50−500 pg/mL 65
Si NW-ISFETs functionalized with
gold nanoparticles
23 fg/mL to 500 ng/mL 17
Si NW-ISFET arrays 1 pg/mL to 1 μg/mL current
study
complementary metal oxide
semiconductor compatible Si
NW arrays
1 fg/mL to 1 ng/mL 37
polycrystalline Si NW-ISFETs 5 fg/mL to 500 pg/mL 36
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threshold voltages of the Si NW-ISFET sensors (compare
Figures 2 and 4).68 Nanowire structures comprise highly p-
doped individual drains and a common source contact, which
are etched out of the top silicon layer of the SOI wafers. The
nanowire regions of typically 15 μm length and 100−200 nm
width are left intrinsic and depending on the thickness of the
silicon (40−60 nm) are either fully or partly depleted, which
leads to the accumulation type transistor characteristics. The
etching proﬁle results in trapezoid cross sections,69 which are
covered by a thin SiO2 gate oxide of 6−8 nm in an almost
wrapped around gate structure, which is partly still in contact
with the BOX supporting the mechanic stability and giving the
possibility for back gating. Typically, we fabricate devices with
subthreshold swings of 100−120 mV/dec,68 which is far away
from the ideal values of about 60 mV/dec. Most likely, the
quality of the gate oxide could be further improved by
annealing in forming gas to decrease the subthreshold slope
values. For biosensor applications, this subthreshold swing
should show a minimum hysteresis. In addition, the channel-
to-channel and the chip-to-chip variations in the Si NW should
be small to enable diﬀerential readout and robustness of the
biosensor assays. Over the past years we opimized the
fabrication process in diﬀerent steps and published these
protocols earlier.27,68−71
The sensor chips with arrays of Si NW-ISFETs measured 10
mm in length and 7 mm in width. The chips were wire-bonded
onto specially designed PCBs. The wire bonds and the contact
lines were then covered with PDMS to protect them from
damage.
Fabrication of the Microﬂuidic Channels. A soft
lithography process for the realization of PDMS microﬂuidic
channels was described in an earlier report.72 In short, an
aluminum mask with ﬂuidic channel designs was patterned
using optical lithography. The ﬂuidic channel structures were
then transferred to a SU-8 resist layer by patterning in another
lithography process. The patterned SU-8 served as a mold for
the production of microﬂuidic channels in the PDMS layer.
The PDMS layer (with microchannel width = 100 μm, height
= 20 μm, and length = 4 mm) was sealed onto the sensor chip
by subjecting both to an UV−ozone treatment for 5 min at
28−32 mW/cm2 (UVO cleaner 144AX, Jelight Company Inc.,
CA). The surface-oxidized PDMS and Si NW-ISFET chips
were then aligned and gently pressed to ensure bonding. After
1 day, the microﬂuidic devices were permanently sealed (as
shown in Figure 1e,f) and ready to be used for the
chemiluminescence assays.
Biofunctional Layer Immobilization. The surface
modiﬁcation process started with a surface activation step to
increase the density of hydroxyl group on the Si NW surfaces.
For this, sensor chips were treated with freshly prepared
piranha solution (H2O2/H2SO4 1:3) for 10 min at 60° C. A
gas-phase silanization process was followed for rendering the Si
NW surfaces with ultrathin GPTMS siloxane layers, which is
detailed in our previous report.27 Eight hundred picoliter
volume of 2 μM PSA-speciﬁc aptamers in 10 mM PB was used
for functionalization of aptamers onto the Si NWs with or
without using a microspotting device (see the Supporting
Information S3). The chips were incubated in a humid
environment (overnight incubation). After the incubation step,
sensor chips were cleaned with 10 mM PB and blow-dried in
N2. To block the remaining GPTMS functional sites, 1 M EA
solution was drop-casted over sensor chips for 30 min,
thoroughly rinsed with deionized water, and blow-dried in N2.
In the end, increasing concentrations of PSA ranging from 1
pg/mL to 1 μg/mL were allowed to bind on the Si NW-
ISFETs chips, each for 2 h in a humid environment
(Supporting Information, Figure 5e). After each PSA
concentration binding, the Si NW-ISFETs chips were rinsed
with 10 mM PB and the electronic characterizations were
done.
Electrical Measurements. For the experiments, where we
compared the performance of the Si NW-ISFET platform with
microscale Si ISFETs (see the Supporting Information S5), a
16-channel, portable ampliﬁer system was used.20 A semi-
conductor parameter analyzer (Keithley 4200, Tektronix
GmbH, Germany) was used for the measurements of Si
NWs in an ISFET conﬁguration. An external Ag/AgCl
reference electrode (DRIREF-450) from World Precision
Instruments GmbH was used as electrochemical gate contact.
In the case of the p-type, microscale Si ISFETs, a drain−source
voltage Vds of −2 V was applied, whereas the gate−source
voltage Vgs was swept from 0 to −2 V. For the Si NW-ISFETs,
a Vds of −100 mV was used, whereas Vgs was swept from 0 to
−1 V. In all the above cases, Vth was calculated by
implementing the transconductance gm extrapolation method
by plotting the ﬁrst derivative of Ids. The Vth is given by the Vgs
axis intercept of the linear extrapolation of gm.
27
Chemiluminescence Assays. Twenty micromolar ap-
tamer solution (0.5 μL/min for 15 min) was ﬂown through the
microﬂuidic channels for covalent immobilization of the
receptor layer. This step was followed by rinsing (5 μL/min
for 1 min with PB) and blocking of the exposed GPTMS sites
using 16 mM EA (0.5 μL/min for 5 min). The Si NWs were
then rinsed with PB (5 μL/min for 1 min). Thereafter, the
sample solutions with diﬀerent concentrations of PSA were
ﬂown into the microﬂuidic channels. In the last step, a solution
with 100 μg/mL anti-PSA-HRP antibodies was ﬂown through
the channels. A ﬂow rate of 10 μL/min was used for luminol to
generate the chemiluminescence and during microscopic
detection. In control experiments, PB solution with 20 μM
of a nonspeciﬁc aptamer sequence (5′-H3N-(CH2)6-AAAAAT-
TAATTTCGAGCGGTAGTTTATCGAAA-3′) was used in-
stead of the PSA-speciﬁc DNA aptamers and ﬂown at the same
rate as with the PSA-speciﬁc aptamer surfaces.
Chemiluminescence Detection. A Leica DMLM ﬂuo-
rescence microscope connected to a Leica DFC300FX digital
camera was used for imaging the microﬂuidic channels and
recording the images. For the optical images, an exposure time
of 200 ms was used with 1× optical gain. The chemilumi-
nescence signal was recorded with an exposure time of 10 s
and 10× optical gain, all in a dark background. The acquired
images were analyzed using ImageJ software (National
Institute of Health). Each PSA concentration was tested by
two independent experiments with respective controls and the
values shown in Figure 3c,d correspond to an average of three
regions of interest in each experiment after the subtraction of
the background signal.
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